THERAPEUTIC COMPOSITIONS COMPRISING THROMBOSERIN OR A SALT THEREOF FOR USE IN THE PREVENTION OR TREATMENT OF THROMBOSIS IN A PATIENT AT RISK OF BLEEDING

摘要

There is provided the use of a 5-HT2A receptor antagonist to treat or prevent thrombosis, particularly arterial thrombosis, in a human or animal patient. The patient is suitably one who is at risk of bleeding, particularly those about to undergo, or those undergoing, surgery. A preferred 5-HT2A antagonist is thromboserin.